203 related articles for article (PubMed ID: 36455524)
1. Potential Embolic Sources in Embolic Stroke of Undetermined Source Patients with Patent Foramen Ovale.
Toh KZX; Koh MY; Ho JSY; Ong KHX; Lee YQ; Chen X; Fang JT; Chong EY; Lim ICZY; Teo YH; Teo YN; Chua CYK; Lim Y; Chan BPL; Sharma VK; Yeo LLL; Sia CH; Tan BYQ
Cerebrovasc Dis; 2023; 52(5):503-510. PubMed ID: 36455524
[TBL] [Abstract][Full Text] [Related]
2. Embolic Stroke of Undetermined Source and Patent Foramen Ovale: Risk of Paradoxical Embolism Score Validation and Atrial Fibrillation Prediction.
Strambo D; Sirimarco G; Nannoni S; Perlepe K; Ntaios G; Vemmos K; Michel P
Stroke; 2021 May; 52(5):1643-1652. PubMed ID: 33784832
[TBL] [Abstract][Full Text] [Related]
3. Comparison of echocardiographic and clinical characteristics in embolic stroke and migraine patients with patent foramen ovale.
Polat F; Kaya Z; Yaylak B; Onuk T
Echocardiography; 2024 Feb; 41(2):e15770. PubMed ID: 38379240
[TBL] [Abstract][Full Text] [Related]
4. Carotid Atherosclerosis and Patent Foramen Ovale in Embolic Stroke of Undetermined Source.
Ntaios G; Sagris D; Strambo D; Perlepe K; Sirimarco G; Georgiopoulos G; Nannoni S; Korompoki E; Manios E; Makaritsis K; Vemmos K; Michel P
J Stroke Cerebrovasc Dis; 2021 Jan; 30(1):105409. PubMed ID: 33137616
[TBL] [Abstract][Full Text] [Related]
5. Embolic stroke of undetermined source: Focusing on atrial cardiopathy and patent foramen ovale.
Zhang M; Xiao Q; Wang K; Yin R; Liu G; Zhao H; Li P; Zhu X; Pan X
Int J Cardiol; 2024 May; 402():131810. PubMed ID: 38272131
[TBL] [Abstract][Full Text] [Related]
6. Localization of Infratentorial Lesion could Predict Patent Foramen Ovale as an Etiology in Embolic Stroke of Undetermined Source.
Ishizuka K; Toi S; Hoshino T; Higuchi E; Kitagawa K
J Atheroscler Thromb; 2022 May; 29(5):785-793. PubMed ID: 33952811
[TBL] [Abstract][Full Text] [Related]
7. Chronic ischemic lesions and presence of patent foramen ovale in young adults with embolic stroke of undetermined source: Results of the young ESUS patient registry.
Meinel TR; Tsiplova K; Taylor A; Meseguer E; Haeusler KG; Hart RG; Arnold M; Perera KS
Int J Stroke; 2024 Apr; 19(4):470-477. PubMed ID: 37981572
[TBL] [Abstract][Full Text] [Related]
8. Atrial Cardiopathy and Likely Pathogenic Patent Foramen Ovale in Embolic Stroke of Undetermined Source.
Leventis IA; Sagris D; Strambo D; Perlepe K; Sirimarco G; Nannoni S; Korompoki E; Manios E; Makaritsis K; Vemmos K; Michel P; Ntaios G
Thromb Haemost; 2021 Mar; 121(3):361-365. PubMed ID: 32877955
[TBL] [Abstract][Full Text] [Related]
9. Ipsilateral Carotid Plaque Presence is Inversely Associated with Patent Foramen Ovale in Cryptogenic Stroke: A Multicenter CohortStudy.
Sathya A; Nguyen TN; Reyes-Esteves S; Kamen S; Hester T; Vigilante N; Woo J; Zhang L; Abdalkader M; Cucchiara B; Siegler JE
J Stroke Cerebrovasc Dis; 2022 Aug; 31(8):106606. PubMed ID: 35749935
[TBL] [Abstract][Full Text] [Related]
10. A score of non-contrast transthoracic echocardiography to screen patent foramen ovale in patients with embolic stroke of undetermined source.
Zhang H; Tang H; Wu F; Yu C; Dong Q; Cao W
BMC Neurol; 2022 Feb; 22(1):43. PubMed ID: 35120481
[TBL] [Abstract][Full Text] [Related]
11. Dabigatran or Aspirin After Embolic Stroke of Undetermined Source in Patients With Patent Foramen Ovale: Results From RE-SPECT ESUS.
Diener HC; Chutinet A; Easton JD; Granger CB; Kleine E; Marquardt L; Meyerhoff J; Zini A; Sacco RL
Stroke; 2021 Mar; 52(3):1065-1068. PubMed ID: 33504190
[TBL] [Abstract][Full Text] [Related]
12. Transcranial Doppler Screening for Patent Foramen Ovale Closure in Cryptogenic Strokes in Young: A Single Center Experience from South India.
Bal D; Ahmed Shaikh AI; Rayani M; Aaron S; Thompson VS; Jose J; Krupa J; Benjamin RN; Rajkumar JL; Prabhakar AT
J Assoc Physicians India; 2022 Oct; 70(10):11-12. PubMed ID: 37355867
[TBL] [Abstract][Full Text] [Related]
13. Catch-up-ESUS - follow-up in embolic stroke of undetermined source (ESUS) in a prospective, open-label, observational study: study protocol and initial baseline data.
Feil K; Heinrich J; Küpper C; Müller K; Laub C; von Falkenhausen AS; Becker R; Wollenweber FA; Kääb S; Sinner MF; Kellert L
BMJ Open; 2019 Dec; 9(12):e031716. PubMed ID: 31822542
[TBL] [Abstract][Full Text] [Related]
14. Comparison of atrial septal defect and patent foramen ovale in cryptogenic strokes.
Delabays C; Correia P; Eeckhout E; Delabays A; Michel P
J Stroke Cerebrovasc Dis; 2024 Jun; 33(6):107664. PubMed ID: 38428550
[TBL] [Abstract][Full Text] [Related]
15. Data-driven machine-learning analysis of potential embolic sources in embolic stroke of undetermined source.
Ntaios G; Weng SF; Perlepe K; Akyea R; Condon L; Lambrou D; Sirimarco G; Strambo D; Eskandari A; Karagkiozi E; Vemmou A; Korompoki E; Manios E; Makaritsis K; Vemmos K; Michel P
Eur J Neurol; 2021 Jan; 28(1):192-201. PubMed ID: 32918305
[TBL] [Abstract][Full Text] [Related]
16. [Ischemic stroke associated with patent foramen ovale: hospital database analysis].
Belopasova AV; Kulesh AA; Mekhryakov SA; Chazov SA; Syromyatnikova LI; Chechetkin AO; Karshieva AR; Kadykov AS
Zh Nevrol Psikhiatr Im S S Korsakova; 2023; 123(3. Vyp. 2):13-19. PubMed ID: 36950816
[TBL] [Abstract][Full Text] [Related]
17. Routine surveillance of pelvic and lower extremity deep vein thrombosis in stroke patients with patent foramen ovale.
Samuel S; Reddy ST; Parsha KN; Nguyen T; Reddy Indupuru HK; Sharrief AZ; Zhu L; McCullough LD; Savitz SI
J Thromb Thrombolysis; 2021 May; 51(4):1150-1156. PubMed ID: 32888135
[TBL] [Abstract][Full Text] [Related]
18. Cardiac and Echocardiographic Markers in Cryptogenic Stroke with Incidental Patent Foramen Ovale.
Tateishi Y; Ueno Y; Tsujino A; Kuriki A; Kamiya Y; Shimizu T; Doijiri R; Yamaguchi E; Kikuno M; Shimada Y; Takekawa H; Koga M; Ihara M; Hirata K; Hasegawa Y; Toyoda K; Hattori N; Urabe T;
J Stroke Cerebrovasc Dis; 2021 Aug; 30(8):105892. PubMed ID: 34107415
[TBL] [Abstract][Full Text] [Related]
19. Risk of Paradoxical Embolism (RoPE)-Estimated Attributable Fraction Correlates With the Benefit of Patent Foramen Ovale Closure: An Analysis of 3 Trials.
Kent DM; Saver JL; Ruthazer R; Furlan AJ; Reisman M; Carroll JD; Smalling RW; Jüni P; Mattle HP; Meier B; Thaler DE
Stroke; 2020 Oct; 51(10):3119-3123. PubMed ID: 32921262
[TBL] [Abstract][Full Text] [Related]
20. From cryptogenic to ESUS: Toward precision medicine?
Timsit S
Rev Neurol (Paris); 2022 Nov; 178(9):939-952. PubMed ID: 35597610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
